FDA Inspection 1152432 — Reproductive Center Of Central New Jersey

Reproductive Center Of Central New Jersey — FEI 3006399783

The FDA completed an inspection of Reproductive Center Of Central New Jersey on Sep 21, 2021 in S Plainfield, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Sep 21, 2021
Fiscal Year
2021
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
S Plainfield, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.